Literature DB >> 15355351

RNA helicase A interacts with nuclear factor kappaB p65 and functions as a transcriptional coactivator.

Toshifumi Tetsuka1, Hiroaki Uranishi, Takaomi Sanda, Kaori Asamitsu, Jiang-Ping Yang, Flossie Wong-Staal, Takashi Okamoto.   

Abstract

RNA helicase A (RHA), a member of DNA and RNA helicase family containing ATPase activity, is involved in many steps of gene expression such as transcription and mRNA export. RHA has been reported to bind directly to the transcriptional coactivator, CREB-binding protein, and the tumor suppressor protein, BRCA1, and links them to RNA Polymerase II holoenzyme complex. Using yeast two-hybrid screening, we have identified RHA as an interacting molecule of the p65 subunit of nuclear factor kappaB (NF-kappaB). The interaction between p65 and RHA was confirmed by glutathione-S transferase pull-down assay in vitro, and by co-immunoprecipitation assay in vivo. In transient transfection assays, RHA enhanced NF-kappaB dependent reporter gene expression induced by p65, tumor necrosis factor-alpha, or NF-kappaB inducing kinase. The mutant form of RHA lacking ATP-binding activity inhibited NF-kappaB dependent reporter gene expression induced by these activators. Moreover, depletion of RHA using short interfering RNA reduced the NF-kappaB dependent transactivation. These data suggest that RHA is an essential component of the transactivation complex by mediating the transcriptional activity of NF-kappaB. Copyright 2004 FEBS

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355351     DOI: 10.1111/j.1432-1033.2004.04314.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  36 in total

Review 1.  RNA helicases: emerging roles in viral replication and the host innate response.

Authors:  Arnaz Ranji; Kathleen Boris-Lawrie
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

2.  DHX9 pairs with IPS-1 to sense double-stranded RNA in myeloid dendritic cells.

Authors:  Zhiqiang Zhang; Bin Yuan; Ning Lu; Valeria Facchinetti; Yong-Jun Liu
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

3.  Genomic implications of H(2)O (2) for cell proliferation and growth of Caco-2 cells.

Authors:  Theresa A Herring; Susan L Cuppett; Janos Zempleni
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

4.  Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.

Authors:  Wenmin Fu; Dinesh Verma; Ashlee Burton; Sankar Swaminathan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

5.  RNA helicase DHX9 may be a therapeutic target in lung cancer and inhibited by enoxacin.

Authors:  Shiguang Cao; Ruiying Sun; Wei Wang; Xia Meng; Yuping Zhang; Na Zhang; Shuanying Yang
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

6.  Human Nup98 regulates the localization and activity of DExH/D-box helicase DHX9.

Authors:  Juliana S Capitanio; Ben Montpetit; Richard W Wozniak
Journal:  Elife       Date:  2017-02-21       Impact factor: 8.140

7.  Poxviral protein E3-altered cytokine production reveals that DExD/H-box helicase 9 controls Toll-like receptor-stimulated immune responses.

Authors:  Alan Dempsey; Sinead E Keating; Michael Carty; Andrew G Bowie
Journal:  J Biol Chem       Date:  2018-08-15       Impact factor: 5.157

8.  TonEBP is inhibited by RNA helicase A via interaction involving the E'F loop.

Authors:  Emanuela Colla; Sang D Lee; Mee R Sheen; Seung K Woo; H Moo Kwon
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

9.  Identification of proteins within the nuclear factor-kappa B transcriptional complex including estrogen receptor-alpha.

Authors:  Irv Feldman; Gerald M Feldman; Charlotte Mobarak; Jeffrey C Dunkelberg; Kimberly K Leslie
Journal:  Am J Obstet Gynecol       Date:  2007-04       Impact factor: 8.661

10.  Identification of RNA helicase A as a new host factor in the replication cycle of foot-and-mouth disease virus.

Authors:  Paul Lawrence; Elizabeth Rieder
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.